Table 1.
Demographic data and magnetic resonance findings of all subjects.
| Patient no. | Origin site | Typical FINDINGS |
Atypical findings | Anti-HIV Ab | Tb | CSF | Drug resistance | |
|---|---|---|---|---|---|---|---|---|
| Meningitis | Tuberculoma | |||||||
| 1 | Lung | – | x | – | – | Positive | – | – |
| 2 | Lung | x | x | x | Negative | Positive | – | Sensitive |
| 3 | Lung | – | x | – | Negative | Positive | – | Resistant (INH) |
| 4 | Lung | x | x | o | Negative | Positive | – | Sensitive |
| 5 | Lung | – | x | x | Negative | Positive | – | Sensitive |
| 6 | Lung | x | x | o | Negative | Positive | – | Resistant (INH, RFP) |
| 7 | Lung | x | x | x | Negative | Positive | – | Resistant (INH, SM) |
| 8 | Lung | x | x | o | Negative | Positive | – | Sensitive |
| 9 | Lung | x | x | x | Negative | Positive | – | – |
| 10 | Lung | o | o (multiple) | x | Negative | Positive | Positive | – |
| 11 | Spine | – | x | x | Negative | Negative | – | – |
| 12 | Spine | x | x | x | Negative | Negative | – | – |
| 13 | Spine | x | x | x | Negative | Negative | – | – |
| 14 | Spine | o | x | x | Negative | Positive | – | – |
| 15 | Spine | o | x | x | Negative | Positive | – | Sensitive |
| 16 | Spine | – | x | x | Negative | Negative | – | – |
| 17 | Spine | – | x | x | Negative | Negative | – | – |
| 18 | Spine | x | x | x | Negative | Negative | – | – |
| 19 | Disseminated | x | o (multiple) | x | Negative | Positive | Positive | Sensitive |
| 20 | Disseminated | o | o (multiple) | o | Negative | Positive | Positive | Sensitive |
| 21 | Disseminated | x | x | x | Negative | Positive | – | – |
| 22 | Unknown | o | x | o | Negative | Positive | Positive | Sensitive |
FLAIR, fluid-attenuated inversion recovery; SI, signal intensity; HIV, human immunodeficiency virus; Ab, antibody; TB, tuberculosis; CSF, cerebrospinal fluid; INH, isoniazid; RFP, rifampin; SM, streptomycin.